HCA Healthcare Inc (NYSE:HCA) – Research analysts at Jefferies Financial Group issued their FY2020 earnings per share (EPS) estimates for shares of HCA Healthcare in a note issued to investors on Thursday, September 20th, according to Zacks Investment Research. Jefferies Financial Group analyst B. Tanquilut anticipates that the company will post earnings of $11.50 per share for the year. Jefferies Financial Group currently has a “Buy” rating and a $155.00 price objective on the stock.
Several other equities analysts also recently commented on the company. Citigroup upped their price objective on HCA Healthcare from $136.00 to $156.00 and gave the company a “buy” rating in a research report on Thursday. Robert W. Baird upped their price objective on HCA Healthcare from $130.00 to $150.00 and gave the company a “positive” rating in a research report on Thursday, September 20th. Bank of America upped their price objective on HCA Healthcare from $125.00 to $135.00 and gave the company an “underperform” rating in a research report on Tuesday, September 18th. Royal Bank of Canada upped their price objective on HCA Healthcare to $150.00 and gave the company an “outperform” rating in a research report on Monday, September 10th. Finally, Argus upped their price objective on HCA Healthcare to $150.00 and gave the company a “buy” rating in a research report on Friday, September 7th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $135.19.
HCA Healthcare stock traded up $1.43 during mid-day trading on Friday, hitting $133.86. The company’s stock had a trading volume of 1,454,880 shares, compared to its average volume of 1,908,900. The company has a market capitalization of $48.14 billion, a PE ratio of 20.31, a price-to-earnings-growth ratio of 1.23 and a beta of 0.49. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of -7.64. HCA Healthcare has a one year low of $71.18 and a one year high of $141.11.
HCA Healthcare (NYSE:HCA) last released its earnings results on Wednesday, July 25th. The company reported $2.29 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.16 by $0.13. The firm had revenue of $11.53 billion for the quarter, compared to the consensus estimate of $11.32 billion. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.73 EPS.
Several hedge funds and other institutional investors have recently modified their holdings of HCA. FMR LLC lifted its stake in shares of HCA Healthcare by 54.9% during the 2nd quarter. FMR LLC now owns 5,488,273 shares of the company’s stock worth $563,097,000 after purchasing an additional 1,944,961 shares during the last quarter. Renaissance Technologies LLC lifted its stake in shares of HCA Healthcare by 187.9% during the 2nd quarter. Renaissance Technologies LLC now owns 1,094,431 shares of the company’s stock worth $112,289,000 after purchasing an additional 714,331 shares during the last quarter. LSV Asset Management lifted its stake in shares of HCA Healthcare by 9.2% during the 2nd quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock worth $560,133,000 after purchasing an additional 457,752 shares during the last quarter. Millennium Management LLC lifted its stake in shares of HCA Healthcare by 32.3% during the 2nd quarter. Millennium Management LLC now owns 1,698,536 shares of the company’s stock worth $174,270,000 after purchasing an additional 414,877 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its stake in shares of HCA Healthcare by 62.6% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 891,489 shares of the company’s stock worth $91,466,000 after purchasing an additional 343,121 shares during the last quarter. Hedge funds and other institutional investors own 70.40% of the company’s stock.
In related news, SVP Victor L. Campbell sold 22,782 shares of the company’s stock in a transaction on Friday, August 3rd. The stock was sold at an average price of $127.12, for a total transaction of $2,896,047.84. Following the completion of the sale, the senior vice president now directly owns 202,650 shares in the company, valued at approximately $25,760,868. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Jane D. Englebright sold 6,543 shares of the company’s stock in a transaction on Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total value of $849,673.98. Following the sale, the senior vice president now owns 7,443 shares of the company’s stock, valued at $966,547.98. The disclosure for this sale can be found here. Insiders have sold a total of 170,257 shares of company stock worth $21,118,053 in the last three months. Corporate insiders own 2.80% of the company’s stock.
The company also recently declared a quarterly dividend, which was paid on Friday, September 28th. Stockholders of record on Tuesday, September 4th were given a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date of this dividend was Friday, August 31st. HCA Healthcare’s payout ratio is 21.24%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Story: How to calculate the intrinsic value of a stock
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.